{
    "paper_id": "PMC7199691",
    "metadata": {
        "title": "The role of ACEIs/ARBs in COVID-19: friend or foe?",
        "authors": [
            {
                "first": "Zhe",
                "middle": [],
                "last": "Zhou",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Yumin",
                "middle": [],
                "last": "Qiu",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Jun",
                "middle": [],
                "last": "Tao",
                "suffix": "",
                "email": "taojungz123@163.com",
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "The Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the most pressing public health challenge at present globally. Recent studies found Angiotensin converting enzyme 2 (ACE2), a homologue of ACE, mediates the the fusion of SARS-CoV-2 and host cells[1]. Therefore, upregulation of ACE2 may increase the susceptibility of the disease. However, there are evidences implying that increased expression of ACE2 may benefit the patient via inhibiting inflammation[2], indicating that the dual role of ACE2. As a common drug in clinic, ACEIs/ARBs increase the expression of ACE2[3], thus it may be a friend or a foe in the COVID-19 management.",
            "cite_spans": [
                {
                    "start": 310,
                    "end": 313,
                    "mention": "[1]",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 518,
                    "end": 521,
                    "mention": "[2]",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 632,
                    "end": 635,
                    "mention": "[3]",
                    "ref_id": "BIBREF2"
                }
            ],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "Most recently a retrospective study found that among COVID-19 patients with hypertension, inpatient use of ACEIs/ARBs was associated with lower risk of all-cause mortality compared with non-users[4], implying that ACEIs/ARBs is a friend of COVID-19. However, there is still insufficient evidence demonstrating this is the case due to the potential residual confounders.",
            "cite_spans": [
                {
                    "start": 195,
                    "end": 198,
                    "mention": "[4]",
                    "ref_id": "BIBREF3"
                }
            ],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "Standing at the crossroads, we need further investigations to delineate the relationship between ACEIs/ARBs and COVID-19: (1) To simulate the disease state of COVID-19, animal disease models are needed to be constructed to elucidate the pathogenicity and biological effects of 2019-nCoV and its connection with ACEIs/ARBs treatment. (2) Molecular mechanism studies are required to screen effective therapeutic schedule for COVID-19. (3) A well-designed prospective clinical research is needed on this issue. In conclusion, complex interactions among ACEIs/ARBs, ACE2 and COVID-19 patients argue for further research to distinguish ACEIs/ARBs as a friend or a foe.",
            "cite_spans": [],
            "section": "",
            "ref_spans": []
        }
    ],
    "ref_entries": {},
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation",
            "authors": [
                {
                    "first": "D.",
                    "middle": [],
                    "last": "Wrapp",
                    "suffix": ""
                },
                {
                    "first": "N.",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "K.S.",
                    "middle": [],
                    "last": "Corbett",
                    "suffix": ""
                },
                {
                    "first": "J.A.",
                    "middle": [],
                    "last": "Goldsmith",
                    "suffix": ""
                },
                {
                    "first": "C.L.",
                    "middle": [],
                    "last": "Hsieh",
                    "suffix": ""
                },
                {
                    "first": "O.",
                    "middle": [],
                    "last": "Abiona",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Science.",
            "volume": "367",
            "issn": "6483",
            "pages": "1260-1263",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF1": {
            "title": "Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet",
            "authors": [
                {
                    "first": "Z.",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Shi",
                    "suffix": ""
                },
                {
                    "first": "Y.",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Respiratory Medicine.",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2",
            "authors": [
                {
                    "first": "C.M.",
                    "middle": [],
                    "last": "Ferrario",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Jessup",
                    "suffix": ""
                },
                {
                    "first": "M.C.",
                    "middle": [],
                    "last": "Chappell",
                    "suffix": ""
                },
                {
                    "first": "D.B.",
                    "middle": [],
                    "last": "Averill",
                    "suffix": ""
                },
                {
                    "first": "K.B.",
                    "middle": [],
                    "last": "Brosnihan",
                    "suffix": ""
                },
                {
                    "first": "E.A.",
                    "middle": [],
                    "last": "Tallant",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Circulation.",
            "volume": "111",
            "issn": "20",
            "pages": "2605-2610",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19",
            "authors": [
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Zhu",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Cai",
                    "suffix": ""
                },
                {
                    "first": "F.",
                    "middle": [],
                    "last": "Lei",
                    "suffix": ""
                },
                {
                    "first": "J.J.",
                    "middle": [],
                    "last": "Qin",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Xie",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Circ Res",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        }
    }
}